Lost in disruption: role of proteases in glioma invasion and progression - PubMed (original) (raw)

Review

. 2012 Apr;1825(2):178-85.

doi: 10.1016/j.bbcan.2011.12.001. Epub 2011 Dec 22.

Affiliations

• PMID: 22209868
• DOI: 10.1016/j.bbcan.2011.12.001

Review

Lost in disruption: role of proteases in glioma invasion and progression

Rolf Mentlein et al. Biochim Biophys Acta. 2012 Apr.

Abstract

A characteristic feature of malignant glial tumors (gliomas) is their tendency to diffusely infiltrate the nervous system preventing their complete surgical resection. Proteases play a decisive role in this malignant process, either by degradation of brain extracellular matrix (ECM) components, adhesion molecules, or by regulating the activity of growth and chemotactic factors. Secreted matrix metalloproteinases (MMPs) and ADAMTS proteases (ADAMs with thrombospondin motifs) cleave different ECM components like the proteoglycans (lecticans) aggrecan, versican, neurocan and brevican with selective preferences; they are further regulated by endogenous inhibitors and activating metallo- and serine proteases. Cell surface proteases of the ADAM family (A Disintegrin And Metalloproteinase), but also serine proteases regulate the activity of growth factors and chemokines that act as autocrine / paracrine stimulators within gliomas. Thus, proteases play a decisive role for the spread and growth of gliomas and are prominent targets for their therapy.

Copyright © 2012 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Similar articles

• Matrix metalloproteinases and their biological function in human gliomas.
  Chintala SK, Tonn JC, Rao JS. Chintala SK, et al. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):495-502. doi: 10.1016/s0736-5748(99)00010-6. Int J Dev Neurosci. 1999. PMID: 10571411 Review.
• Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.
  Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Bellail AC, et al. Int J Biochem Cell Biol. 2004 Jun;36(6):1046-69. doi: 10.1016/j.biocel.2004.01.013. Int J Biochem Cell Biol. 2004. PMID: 15094120 Review.
• The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
  VanMeter TE, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ. VanMeter TE, et al. J Neurooncol. 2001 Jun;53(2):213-35. doi: 10.1023/a:1012280925031. J Neurooncol. 2001. PMID: 11716072 Review.
• [Role of extracellular matrix degradation enzyme for glioma invasion].
  Nakada M. Nakada M. Nihon Rinsho. 2005 Sep;63 Suppl 9:55-60. Nihon Rinsho. 2005. PMID: 16201500 Review. Japanese. No abstract available.
• Mechanisms of glioma invasion: role of matrix-metalloproteinases.
  Uhm JH, Dooley NP, Villemure JG, Yong VW. Uhm JH, et al. Can J Neurol Sci. 1997 Feb;24(1):3-15. doi: 10.1017/s0317167100021028. Can J Neurol Sci. 1997. PMID: 9043741 Review.

Cited by

• Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.
  Whitehead CA, Nguyen HPT, Morokoff AP, Luwor RB, Paradiso L, Kaye AH, Mantamadiotis T, Stylli SS. Whitehead CA, et al. Transl Oncol. 2018 Dec;11(6):1406-1418. doi: 10.1016/j.tranon.2018.08.012. Epub 2018 Sep 13. Transl Oncol. 2018. PMID: 30219696 Free PMC article.
• Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy.
  Tewari BP, Chaunsali L, Campbell SL, Patel DC, Goode AE, Sontheimer H. Tewari BP, et al. Nat Commun. 2018 Nov 9;9(1):4724. doi: 10.1038/s41467-018-07113-0. Nat Commun. 2018. PMID: 30413686 Free PMC article.
• Glycation Leads to Increased Invasion of Glioblastoma Cells.
  Schildhauer P, Selke P, Scheller C, Strauss C, Horstkorte R, Leisz S, Scheer M. Schildhauer P, et al. Cells. 2023 Apr 23;12(9):1219. doi: 10.3390/cells12091219. Cells. 2023. PMID: 37174618 Free PMC article.
• Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.
  Beladi RN, Varkoly KS, Schutz L, Zhang L, Yaron JR, Guo Q, Burgin M, Hogue I, Tierney W, Dobrowski W, Lucas AR. Beladi RN, et al. Curr Neuropharmacol. 2021;19(11):1835-1854. doi: 10.2174/1570159X19666210225154835. Curr Neuropharmacol. 2021. PMID: 33632104 Free PMC article. Review.
• ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas.
  Fan X, Wang Y, Zhang C, Liu L, Yang S, Wang Y, Liu X, Qian Z, Fang S, Qiao H, Jiang T. Fan X, et al. Int J Mol Sci. 2016 Aug 26;17(9):1276. doi: 10.3390/ijms17091276. Int J Mol Sci. 2016. PMID: 27571068 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information